• Other
  • Exited

Hypnion Inc. is a wholly owned subsidiary of Eli Lilly and Company(www.lilly.com).  We are focused on the development of novel therapeutics for the treatment of central nervous system (CNS) disorders to serve the vastly underserved markets of sleep and wake-alertness disorders and circadian rhythm abnormalities. Hypnion, Inc. was acquired by Eli Lilly.